$AMWL

HIRSCHHORN MARK sold $40K of AMWL

HIRSCHHORN MARK (Chief Financial Officer) sold 4,299 shares of American Well Corp (AMWL) at $9.33 on 2026-07-01.

Original reporting
SEC EDGAR · HIRSCHHORN MARK
Published Jul 1, 2026, 9:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 9:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMWL
Neutral
medium confidence
Mentioned
$AMWL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWLNeutralLow
01

Why it matters

The disclosure provides incremental sentiment information (insider selling) but does not include new guidance, financial results, or legal/operational developments.

02

Market read

Traders may note insider selling, but the transaction’s size and lack of accompanying catalysts suggest limited tradable impact.

03

What to watch

No 10b5-1 plan is cited, but the filing does not provide intent, and insider sales can be scheduled or driven by personal liquidity needs.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-01 (after-hours) for an insider sale dated 2026-07-01

Background

This is an SEC Form 4 insider transaction disclosure for American Well Corp (AMWL).

Company-level read

Ticker impact

$AMWLNeutralMedium confidence
Context

AMWL CFO Mark Hirschhorn sold 4,299 shares in an open-market transaction on 2026-07-01, per the Form 4 filing.

Expected impact

Likely limited near-term impact; any reaction would be small unless accompanied by other company-specific news.

Evidence & confidence

The article is a primary-source Form 4 showing a modest dollar-value sale (~$40.1k) with no stated reason or accompanying operational/regulatory update.

Market effects

Minimal; single-company insider sale does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

The sale may be unrelated to fundamentals (tax/portfolio rebalancing), especially given the small value relative to typical institutional trading flows.

Key entities

  • AMWL

    American Well Corp; subject of the insider transaction disclosure.

  • Mark Hirschhorn

    CFO of AMWL who sold shares via an open-market sale.

Related articles

$QTTBMedAI 8/10

Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus

Biotech gainers highlighted Q32 Bio (QTTB), up 90.7% to $21.38 after positive Phase 2 SIGNAL-AA results for bempikibart in alopecia areata, and it launched a $200M underwritten stock offering. Agenus (AGEN) rose 82.7% to $6.12 on a planned ~$85M private placement for BOT+BAL Phase 3 ROBBIN1. Other movers: ACTU, GALT, AMWL, SI.